Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters’ Levels, but Has No Effect on Body Composition Parameters

BACKGROUND: Psoriasis is frequently accompanied by metabolic syndrome. Effect of anti-tumor necrosis factor therapies on increases in body weight is well-known. Data on the effects of interleukin-17 inhibitors are limited. Authors determined the effect of anti-interleukin-17 therapies on the body co...

Descripción completa

Detalles Bibliográficos
Autores principales: Piros, Éva Anna, Szabó, Ákos, Rencz, Fanni, Brodszky, Valentin, Wikonkál, Norbert, Miheller, Pál, Horváth, Miklós, Holló, Péter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228146/
https://www.ncbi.nlm.nih.gov/pubmed/34207504
http://dx.doi.org/10.3390/life11060535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228146/
https://www.ncbi.nlm.nih.gov/pubmed/34207504
http://dx.doi.org/10.3390/life11060535

Ejemplares similares